Selected research
Industry Growth & Trends
Global Fosfomycin Sodium Industry Growth and Trends Forecast to 2032
Market perspective
The global Fosfomycin Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fosfomycin Sodium include New Asia Pharma, Dorrapharma, Merck KGaA, FarmaSino Pharmaceutical, Hubei Xunda Pharmaceutical, Northeast Pharma, Sundent Pharm Group, Shin Poong Pharm and National Analytical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fosfomycin Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fosfomycin Sodium market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fosfomycin Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fosfomycin Sodium.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fosfomycin Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fosfomycin Sodium Market by Company
New Asia Pharma
Dorrapharma
Merck KGaA
FarmaSino Pharmaceutical
Hubei Xunda Pharmaceutical
Northeast Pharma
Sundent Pharm Group
Shin Poong Pharm
National Analytical Corporation
Ercros
Fosfomycin Sodium Segment by Type
Tablets
Injection
Fosfomycin Sodium Segment by Application
Hospital
Clinic
Other
Fosfomycin Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fosfomycin Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fosfomycin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Hospital
- Clinic
- Other
Companies covered
- New Asia Pharma
- Dorrapharma
- Merck KGaA
- FarmaSino Pharmaceutical
- Hubei Xunda Pharmaceutical
- Northeast Pharma
- Sundent Pharm Group
- Shin Poong Pharm
- National Analytical Corporation
- Ercros
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fosfomycin Sodium Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fosfomycin Sodium Sales Estimates and Forecasts (2021-2032)
- 1.3 Fosfomycin Sodium Market by Type
- 1.3.1 Tablets
- 1.3.2 Injection
- 1.4 Global Fosfomycin Sodium Market Size by Type
- 1.4.1 Global Fosfomycin Sodium Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fosfomycin Sodium Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fosfomycin Sodium Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fosfomycin Sodium Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fosfomycin Sodium Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fosfomycin Sodium Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fosfomycin Sodium Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fosfomycin Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fosfomycin Sodium Industry Trends
- 2.2 Fosfomycin Sodium Industry Drivers
- 2.3 Fosfomycin Sodium Industry Opportunities and Challenges
- 2.4 Fosfomycin Sodium Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fosfomycin Sodium Revenue (2021-2026)
- 3.2 Global Top Players by Fosfomycin Sodium Sales (2021-2026)
- 3.3 Global Top Players by Fosfomycin Sodium Price (2021-2026)
- 3.4 Global Fosfomycin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fosfomycin Sodium Major Company Production Sites & Headquarters
- 3.6 Global Fosfomycin Sodium Company, Product Type & Application
- 3.7 Global Fosfomycin Sodium Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fosfomycin Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fosfomycin Sodium Players Market Share by Revenue in 2025
- 3.8.3 2025 Fosfomycin Sodium Tier 1, Tier 2, and Tier 3
4 Fosfomycin Sodium Regional Status and Outlook
- 4.1 Global Fosfomycin Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fosfomycin Sodium Historic Market Size by Region
- 4.2.1 Global Fosfomycin Sodium Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fosfomycin Sodium Sales in Value by Region (2021-2026)
- 4.2.3 Global Fosfomycin Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fosfomycin Sodium Forecasted Market Size by Region
- 4.3.1 Global Fosfomycin Sodium Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fosfomycin Sodium Sales in Value by Region (2027-2032)
- 4.3.3 Global Fosfomycin Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fosfomycin Sodium by Application
- 5.1 Fosfomycin Sodium Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Fosfomycin Sodium Market Size by Application
- 5.2.1 Global Fosfomycin Sodium Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fosfomycin Sodium Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fosfomycin Sodium Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fosfomycin Sodium Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fosfomycin Sodium Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fosfomycin Sodium Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fosfomycin Sodium Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fosfomycin Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 New Asia Pharma
- 6.1.1 New Asia Pharma Company Information
- 6.1.2 New Asia Pharma Business Overview
- 6.1.3 New Asia Pharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 New Asia Pharma Fosfomycin Sodium Product Portfolio
- 6.1.5 New Asia Pharma Recent Developments
- 6.2 Dorrapharma
- 6.2.1 Dorrapharma Company Information
- 6.2.2 Dorrapharma Business Overview
- 6.2.3 Dorrapharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Dorrapharma Fosfomycin Sodium Product Portfolio
- 6.2.5 Dorrapharma Recent Developments
- 6.3 Merck KGaA
- 6.3.1 Merck KGaA Company Information
- 6.3.2 Merck KGaA Business Overview
- 6.3.3 Merck KGaA Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck KGaA Fosfomycin Sodium Product Portfolio
- 6.3.5 Merck KGaA Recent Developments
- 6.4 FarmaSino Pharmaceutical
- 6.4.1 FarmaSino Pharmaceutical Company Information
- 6.4.2 FarmaSino Pharmaceutical Business Overview
- 6.4.3 FarmaSino Pharmaceutical Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio
- 6.4.5 FarmaSino Pharmaceutical Recent Developments
- 6.5 Hubei Xunda Pharmaceutical
- 6.5.1 Hubei Xunda Pharmaceutical Company Information
- 6.5.2 Hubei Xunda Pharmaceutical Business Overview
- 6.5.3 Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio
- 6.5.5 Hubei Xunda Pharmaceutical Recent Developments
- 6.6 Northeast Pharma
- 6.6.1 Northeast Pharma Company Information
- 6.6.2 Northeast Pharma Business Overview
- 6.6.3 Northeast Pharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Northeast Pharma Fosfomycin Sodium Product Portfolio
- 6.6.5 Northeast Pharma Recent Developments
- 6.7 Sundent Pharm Group
- 6.7.1 Sundent Pharm Group Company Information
- 6.7.2 Sundent Pharm Group Business Overview
- 6.7.3 Sundent Pharm Group Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sundent Pharm Group Fosfomycin Sodium Product Portfolio
- 6.7.5 Sundent Pharm Group Recent Developments
- 6.8 Shin Poong Pharm
- 6.8.1 Shin Poong Pharm Company Information
- 6.8.2 Shin Poong Pharm Business Overview
- 6.8.3 Shin Poong Pharm Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Shin Poong Pharm Fosfomycin Sodium Product Portfolio
- 6.8.5 Shin Poong Pharm Recent Developments
- 6.9 National Analytical Corporation
- 6.9.1 National Analytical Corporation Company Information
- 6.9.2 National Analytical Corporation Business Overview
- 6.9.3 National Analytical Corporation Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 National Analytical Corporation Fosfomycin Sodium Product Portfolio
- 6.9.5 National Analytical Corporation Recent Developments
- 6.10 Ercros
- 6.10.1 Ercros Company Information
- 6.10.2 Ercros Business Overview
- 6.10.3 Ercros Fosfomycin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Ercros Fosfomycin Sodium Product Portfolio
- 6.10.5 Ercros Recent Developments
7 North America by Country
- 7.1 North America Fosfomycin Sodium Sales by Country
- 7.1.1 North America Fosfomycin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fosfomycin Sodium Sales by Country (2021-2026)
- 7.1.3 North America Fosfomycin Sodium Sales Forecast by Country (2027-2032)
- 7.2 North America Fosfomycin Sodium Market Size by Country
- 7.2.1 North America Fosfomycin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fosfomycin Sodium Market Size by Country (2021-2026)
- 7.2.3 North America Fosfomycin Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fosfomycin Sodium Sales by Country
- 8.1.1 Europe Fosfomycin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fosfomycin Sodium Sales by Country (2021-2026)
- 8.1.3 Europe Fosfomycin Sodium Sales Forecast by Country (2027-2032)
- 8.2 Europe Fosfomycin Sodium Market Size by Country
- 8.2.1 Europe Fosfomycin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fosfomycin Sodium Market Size by Country (2021-2026)
- 8.2.3 Europe Fosfomycin Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fosfomycin Sodium Sales by Country
- 9.1.1 Asia-Pacific Fosfomycin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fosfomycin Sodium Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fosfomycin Sodium Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fosfomycin Sodium Market Size by Country
- 9.2.1 Asia-Pacific Fosfomycin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fosfomycin Sodium Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fosfomycin Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fosfomycin Sodium Sales by Country
- 10.1.1 South America Fosfomycin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fosfomycin Sodium Sales by Country (2021-2026)
- 10.1.3 South America Fosfomycin Sodium Sales Forecast by Country (2027-2032)
- 10.2 South America Fosfomycin Sodium Market Size by Country
- 10.2.1 South America Fosfomycin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fosfomycin Sodium Market Size by Country (2021-2026)
- 10.2.3 South America Fosfomycin Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fosfomycin Sodium Sales by Country
- 11.1.1 Middle East and Africa Fosfomycin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fosfomycin Sodium Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fosfomycin Sodium Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fosfomycin Sodium Market Size by Country
- 11.2.1 Middle East and Africa Fosfomycin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fosfomycin Sodium Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fosfomycin Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fosfomycin Sodium Value Chain Analysis
- 12.1.1 Fosfomycin Sodium Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fosfomycin Sodium Production Mode & Process
- 12.2 Fosfomycin Sodium Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fosfomycin Sodium Distributors
- 12.2.3 Fosfomycin Sodium Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst